Growth After Conversion to Alternate-day Corticosteroids in Children with Renal Transplants: a Single-center Study

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 1994 Jun 1

PMID 7917858

Citations 2

Authors

B A Kaiser

M S Polinsky

J A Palmer

S Dunn

M Mochon

J T Flynn

H J Baluarte

Affiliations

Soon will be listed here.

Abstract

During the 1980s all children with growth potential and stable/adequate renal function at 6-9 months after kidney transplantation underwent conversion to alternate-day corticosteroids in an attempt to maximize growth. Conversion was attempted in 79 of 160 children who received allografts during this decade and was considered successful if they remained on alternate-day prednisone for more than 1 year, with a calculated creatinine clearance of at least 75% of the pre-conversion baseline value. Conversion succeeded in 55 children but failed in 24. Growth was markedly improved among those successfully converted when compared with the failure group, as measured by standard deviation score for growth velocity based on chronological age (+0.94 +/- 1.58 vs. -0.86 +/- 1.53, P < 0.001) and bone age (+0.49 +/- 0.61 vs. -1.24 +/- 1.47, P < 0.001). The improved growth among the successfully converted patients is believed to have been related to the combined effects of lower corticosteroid dose (0.36 +/- 0.16 vs. 0.48 +/- 0.21 mg/kg per day, P < 0.02) and better renal function (calculated creatinine clearance 87 +/- 32 vs. 47 +/- 21 ml/min per 1.73 m2, P < 0.001) at 1 year post conversion. Two factors appeared to improve the likelihood of successful conversion: the use of cyclosporine and receiving a live-related rather than cadaver transplant. Cyclosporine was associated with improvement in the overall rate for successful conversion in all recipients, from 59% to 83% (P < 0.05). Recipients of allografts from live-related donors underwent successful conversion in 90% of cases compared with 58% receiving cadaver allografts (P < 0.05). (ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapy.

Hamada R, Kaku Y, Inaba A, Kaito H, Kimata T, Kondo S Clin Exp Nephrol. 2025; .

PMID: 40063214 DOI: 10.1007/s10157-025-02636-5.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy.

Kaku Y, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H Clin Exp Nephrol. 2015; 19(1):34-53.

PMID: 25653047 DOI: 10.1007/s10157-014-1031-9.

Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants.

Chavatte C, Guest G, Proust V, Le Bihan C, Gimenez F, Maisin A Pediatr Nephrol. 2004; 19(8):898-904.

PMID: 15197639 DOI: 10.1007/s00467-004-1497-x.

References

Baumgartner R, Roche A, Himes J . Incremental growth tables: supplementary to previously published charts. Am J Clin Nutr. 1986; 43(5):711-22. DOI: 10.1093/ajcn/43.5.711. View

Hyams J, Carey D . Corticosteroids and growth. J Pediatr. 1988; 113(2):249-54. DOI: 10.1016/s0022-3476(88)80260-9. View

Guest G, Broyer M . Growth after renal transplantation: correlation with immunosuppressive therapy. Pediatr Nephrol. 1991; 5(1):143-6. DOI: 10.1007/BF00852872. View

Salaman J . Renal transplantation without steroids. Pediatr Nephrol. 1991; 5(1):105-7. DOI: 10.1007/BF00852865. View

Tejani A, Fine R, Alexander S, Harmon W, Stablein D . Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study. J Pediatr. 1993; 122(3):397-402. DOI: 10.1016/s0022-3476(05)83423-7. View

Tejani A, Butt K, Rajpoot D, Gonzalez R, Buyan N, Pomrantz A . Strategies for optimizing growth in children with kidney transplants. Transplantation. 1989; 47(2):229-33. DOI: 10.1097/00007890-198902000-00006. View

Ettenger R . Children are different: the challenges of pediatric renal transplantation. Am J Kidney Dis. 1992; 20(6):668-72. DOI: 10.1016/s0272-6386(12)70238-x. View

Schwartz G, Haycock G, EDELMANN Jr C, Spitzer A . A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58(2):259-63. View

Reisman L, Lieberman K, Burrows L, Schanzer H . Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation. 1990; 49(1):76-80. DOI: 10.1097/00007890-199001000-00017. View

10.

Nieszporek T, Grzeszczak W, KOKOT F, Zukowska-Szczechowska E, KUSMIERSKI S, SZKODNY A . Influence of type of immunosuppressive therapy on secretion of somatotropin and function of the pituitary-adrenal and pituitary-gonadal axis in patients with a kidney transplant. Nephron. 1989; 53(1):65-9. DOI: 10.1159/000185704. View

11.

Bosque M, Munian A, Bewick M, Haycock G, Chantler C . Growth after renal transplants. Arch Dis Child. 1983; 58(2):110-4. PMC: 1628117. DOI: 10.1136/adc.58.2.110. View

12.

Potter D, Feduska N, Melzer J, Garovoy M, Hopper S, Duca R . Twenty years of renal transplantation in children. Pediatrics. 1986; 77(4):465-70. View

13.

Feldhoff C, Goldman A, Najarian J, MAUER S . A comparison of alternate day and daily steroid therapy in children following renal transplantation. Int J Pediatr Nephrol. 1984; 5(1):11-4. View

14.

Aschendorff C, Offner G, Winkler L, Schirg E, Hoyer P, BRODEHL J . Adult height achieved in children after kidney transplantation. Am J Dis Child. 1990; 144(10):1138-41. DOI: 10.1001/archpedi.1990.02150340084029. View

15.

Fennell R, Moles M, Iravani A, Walker R, Pfaff W, Howard R . Growth in children following kidney transplantation. Pediatr Nephrol. 1990; 4(4):335-9. DOI: 10.1007/BF00862512. View

16.

Koch V, Lippe B, Nelson P, Boechat M, Sherman B, Fine R . Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr. 1989; 115(3):365-71. DOI: 10.1016/s0022-3476(89)80833-9. View

17.

Tonshoff B, Mehis O, Heinrich U, Blum W, Ranke M, Schauer A . Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr. 1990; 116(4):561-6. DOI: 10.1016/s0022-3476(05)81603-8. View

18.

Hamill P, Drizd T, Johnson C, Reed R, Roche A, MOORE W . Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979; 32(3):607-29. DOI: 10.1093/ajcn/32.3.607. View

19.

Ettenger R, Blifeld C, Prince H, Gradus D, Cho S, Sekiya N . The pediatric nephrologist's dilemma: growth after renal transplantation and its interaction with age as a possible immunologic variable. J Pediatr. 1987; 111(6 Pt 2):1022-5. DOI: 10.1016/s0022-3476(87)80049-5. View

20.

Saenger P . Use of growth hormone in the treatment of short stature: boon or abuse?. Pediatr Rev. 1991; 12(12):355-63. View